BEIJING, March 1, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that management will present at the following investment community conferences in March:
- Rodman & Renshaw Annual China Investment Conference in Shanghai, China on March 8, 2011 at 2:25 p.m. Beijing time.
- ROTH 23rd Annual OC Growth Stock Conference in Laguna Niguel, Calif. on March 15, 2011 at 2:00 p.m. Pacific Standard Time.
Investors attending the Rodman & Renshaw or ROTH conference are invited to visit management's formal presentations at the above times and venues. Attending investors are also encouraged to schedule one-on-one meeting with management at these conferences by contacting their sales person at the appropriate conference, or by contacting Lee Roth at (212) 481-2050 or firstname.lastname@example.org.
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA) and HEYER (Germany), Timesco (UK), ResMed (Australia), and JMS (Japan). Dehaier's technology is based on two patents, six pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
In the US:
The Piacente Group, Inc.
Brandi Floberg or Lee Roth
The Piacente Group, Inc.
Dehaier Medical Systems Limited
Investor Relations Manager
+86 10-5166-0080 ext 169
SOURCE Dehaier Medical Systems Ltd.